RoosterBio’s off-the-shelf cell banks and bioprocess media together with the Quantum® Cell Expansion System from Terumo Blood and Cell Technologies allow large-scale hMSC expansion in a functionally closed, automated system that can be readily implemented to enable production of a consistent, clinically relevant therapeutic dose. These factors are essential to meet the demand for consistent and effective final product, which is key to a successful commercialization of an hMSC therapy product.